Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Launch excellence

    April 12, 2022 | Lucid Group, Medical Communications, Pharma, healthcare communications, launch 

    - PMLiVE

    In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines today.

    With a rapidly changing clinical, economic and regulatory environment, the launch of new products has catapulted the pharmaceutical industry into greater complexity and pressure than ever before. Historically, new asset launches have been a tale of two halves: a hit or miss. Between 2009 and 2017, 40% of worldwide drug launches failed to meet their 2-year sales forecasts, according to McKinsey & Company1. Taking into consideration the evolving environment, there has never been a greater need for new models to navigate the path of an asset to market.

    Over the past 15 years, our clients have regularly come to us to help them execute their launch plans. Often the ask is around launch readiness and activation, with a focus on tactical execution. In this article, we discuss the need to get ahead of tactical planning and demonstrate the role of ‘pre-launch asset preparedness’, to ensure we maximise the potential of specialised medicines in this highly complex environment.

    You can read the full article online here or download it so you can read it later here.

    If you’re planning a launch and looking for some advice, get in touch! We’re hosting free launch-strategy clinics throughout May and June. Contact Cheryl Harrison Doyle or Clare Reynolds for more details.

    cheryl.harrisondoyle@wearelucidgroup.com
    07818 568882

    clare.reynolds@wearelucidgroup.com
    07501 989799

    This content was provided by Lucid Group Communications Limited

    Company Details

    - PMLiVE

    Lucid Group Communications Limited

    Email
    Website

     Latest Content from  Lucid Group Communications Limited 

    Lucid Group: What medical communications means to us

    Katherine Duxbury, Scientific Director at Lucid, explains what medical communications means to Lucid: What we do, how we do it and what makes us different.

    Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016

    The PMEA programme rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes. The awards have been specifically designed to recognise and commend excellence, best...

    Lucid bolsters its senior leadership team

    Lucid Group has had a successful summer attracting top talent to its senior leadership team with the appointment of Shula Sarner (Executive Scientific Director) and Tanya Goodyear (Division Director, Immunology).

    IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

    Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

    Lucid Group becomes a sponsor of MedComms Networking

    To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...

    Tenth Lucid Academy module delivered – nurturing talent and driving excellence

    Celebrating the success of the Lucid Academy

    Lucid launch new recruitment campaign to attract top talent in medical writing

    We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

    Knowing your audience is key to successful medical education

    Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

    Making a difference together

    It was highlighted at the 2016 World Economic Forum that ‘good business’ now means more than financial success, with multiple stakeholders asking how business will benefit society. At Lucid, our...

    Lucid Group take time out for work and play at their annual Summer Meeting

    Lucid Group may be an award-winning medical education agency, packed with industry-leading talent, but it still understands how important it is to provide the best customer experience possible. 2015 was an...